Synergistic action of gemcitabine and celecoxib in promoting the antitumor efficacy of anti-programmed death-1 monoclonal antibody by triggering immunogenic cell death

Xiongjie Zhu(Guangzhou Medical University), Yanfang Zheng(State Key Laboratory of Respiratory Disease)
Translational Cancer Research
June 1, 2024
Cited by 3


Related Papers